| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/2011 | US20110224173 C2-C5-Alkyl-Imidazole-Bisphosphonates |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224171 Inhibitors of fatty acid amide hydrolase |
| 09/15/2011 | US20110224170 Pyranopyranone derivatives as antimicrobial agents |
| 09/15/2011 | US20110224169 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 09/15/2011 | US20110224168 Fat-binding compositions |
| 09/15/2011 | US20110224167 Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof |
| 09/15/2011 | US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) |
| 09/15/2011 | US20110224165 Formulations and methods for reducing waist circumference |
| 09/15/2011 | US20110224162 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity of the inflammatory response |
| 09/15/2011 | US20110224161 Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof |
| 09/15/2011 | US20110224160 Use of Escin for Treatment of Type IV Hypersensitivity Reaction |
| 09/15/2011 | US20110224159 Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents |
| 09/15/2011 | US20110224158 Esterified alpha-galactosylceramide |
| 09/15/2011 | US20110224157 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 09/15/2011 | US20110224156 Propionic Acids, Propionic Acid Esters, and Related Compounds |
| 09/15/2011 | US20110224155 Modulation of chemosensory receptors and ligands associated therewith |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224147 Methods and compositions |
| 09/15/2011 | US20110224146 Augmented cognitive training |
| 09/15/2011 | US20110224145 Neuromodulators and Methods of Use |
| 09/15/2011 | US20110224144 Compositions and methods for diagnosing and treating mental disorders |
| 09/15/2011 | US20110224141 Methods and related compositions for the treatment of cancer |
| 09/15/2011 | US20110224137 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224136 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224133 Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases |
| 09/15/2011 | US20110224128 Methods and compositions for treatment of muscular dystrophy |
| 09/15/2011 | US20110224075 Pesticidal Active Mixtures Comprising Aminothiazoline Compounds |
| 09/15/2011 | US20110223687 Method for diagnosing non-small cell lung cancer |
| 09/15/2011 | US20110223642 Method for inhibiting bacteria growth during ethanol fermentation |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223269 Agent for treating eye diseases |
| 09/15/2011 | US20110223264 Substancefor Restoring Normal Co-expression and Interaction Between the LOX and NRAGE Proteins |
| 09/15/2011 | US20110223262 Method of Enhancing Biological Activity of Plant Extracts |
| 09/15/2011 | US20110223260 Mazindol Combindation In The Treatment Of Attention Deficit/Hyperactivity |
| 09/15/2011 | US20110223259 Anti-viral pharmaceutical compositions |
| 09/15/2011 | US20110223257 Releasable fusogenic lipids for nucleic acids delivery systems |
| 09/15/2011 | US20110223256 Method For Stabilizing Flavonoid Aqueous Dispersion |
| 09/15/2011 | US20110223255 Implantable products comprising nanoparticles |
| 09/15/2011 | US20110223254 Functionalized diphenolics and absorbable polymers therefrom |
| 09/15/2011 | US20110223252 Electrolyte purgative |
| 09/15/2011 | US20110223250 Multi-vitamin and mineral nutritional supplements |
| 09/15/2011 | US20110223249 Extended release compositions comprising mycophenolate sodium and processes thereof |
| 09/15/2011 | US20110223248 Methods and compositions for treating lactose intolerance |
| 09/15/2011 | US20110223247 Pharmaceutical compositions for release control of methylphenidate |
| 09/15/2011 | US20110223246 Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source |
| 09/15/2011 | US20110223245 Controlled-release formulations of pramipexole |
| 09/15/2011 | US20110223244 Alcohol resistant enteric pharmaceutical compositions |
| 09/15/2011 | US20110223243 Artificial oxygen carriers and use thereof |
| 09/15/2011 | US20110223241 Combination methods and compositions |
| 09/15/2011 | US20110223239 Spermicidal and virucidal properties of various forms of sophorolipids |
| 09/15/2011 | US20110223238 Bisbenzamidines for the Treatment of Pneumonia |
| 09/15/2011 | US20110223237 Selegiline-containing adhesive preparation |
| 09/15/2011 | US20110223236 Selegiline-containing adhesive preparation |
| 09/15/2011 | US20110223235 Selegiline-containing adhesive preparation |
| 09/15/2011 | US20110223234 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof |
| 09/15/2011 | US20110223233 Microfabricated nanopore device for sustained release of therapeutic agent |
| 09/15/2011 | US20110223232 drug-release composition having a therapeutic carrier |
| 09/15/2011 | US20110223230 Hydrogel formulations |
| 09/15/2011 | US20110223229 Immobilised biological entities |
| 09/15/2011 | US20110223221 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention |
| 09/15/2011 | US20110223217 Block copolymers and uses thereof |
| 09/15/2011 | US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same |
| 09/15/2011 | US20110223214 Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics |
| 09/15/2011 | US20110223213 Highly pure ranolazine or a pharmaceutically acceptable salt thereof |
| 09/15/2011 | US20110223211 Pharmaceutical formulations containing irbesartan |
| 09/15/2011 | US20110223210 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 09/15/2011 | US20110223207 Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same |
| 09/15/2011 | US20110223206 Micelle compositions and process for the preparation thereof |
| 09/15/2011 | US20110223204 Treatment of pain with gap junction modulation compounds |
| 09/15/2011 | US20110223203 Nanocluster compositions and methods |
| 09/15/2011 | US20110223193 Method for the preparation of medical devices and devices obtained therefrom |
| 09/15/2011 | US20110223192 Methods for delaying the onset and/or reducing the severity of metabolic syndrome |
| 09/15/2011 | US20110223189 Agent for treating leishmania infections |
| 09/15/2011 | US20110223188 Targeted costimulatory polypeptides and methods of use to treat cancer |
| 09/15/2011 | US20110223177 Treatment of fibrotic eye disorders |
| 09/15/2011 | US20110223174 Nontypeable Haemophilus Influenzae Virulence Factors |
| 09/15/2011 | US20110223171 Methods and Compositions for the Diagnosis and Treatment of Cyclin A-1 Associated Conditions |
| 09/15/2011 | US20110223167 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/15/2011 | US20110223161 Targeting pax2 for the treatment of breast cancer |
| 09/15/2011 | US20110223158 Association of levels of hdl-cholesterol apolipoprotein ciii with the risk of coronary heart disease and cardiovascular events |
| 09/15/2011 | US20110223157 Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor |
| 09/15/2011 | US20110223153 Modified silk films containing glycerol |
| 09/15/2011 | US20110223152 Use of inhibitors of leukotriene b4 receptor blt2 for treating human cancers |
| 09/15/2011 | US20110223134 Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 09/15/2011 | US20110223132 Isothiazoloquinolones and related compounds as anti-infective agents |
| 09/15/2011 | US20110223131 Antiviral compounds |
| 09/15/2011 | US20110223128 Regulation of microvasculature occlusion |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223126 Ophthalmic composition |
| 09/15/2011 | US20110223118 Antibacterial pharmaceutical composition comprising aceriphyllum rossii extract and active compounds isolated therefrom |
| 09/15/2011 | US20110223115 Sublingual buccal effervescent |
| 09/15/2011 | US20110223111 Calcium carbonate microstructures useful in encapsulation applications and a process for the preparation thereof |
| 09/15/2011 | US20110223105 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis |
| 09/15/2011 | US20110223102 Multimodality agents for tumor imaging and therapy |
| 09/15/2011 | US20110223058 Structure, Synthesis, and Applications for Oligo Phenylene Ethynylenes |
| 09/15/2011 | US20110220539 Synthesis of high molecular weight iron-saccharidic complexes |
| 09/15/2011 | US20110220265 Preparation for External Use |
| 09/15/2011 | DE102011013342A1 New water-soluble or -swellable polymer having repeating structural units comprising amino-sulfur trioxide group containing repeating structural units and repeating crosslinking structural units, useful e.g. as thickener and solubilizer |
| 09/15/2011 | DE102010033301A1 Topically applicable medicament, useful for treating actinic keratosis, comprises diclofenac and chitosan |